收费全文 | 20020篇 |
免费 | 1412篇 |
国内免费 | 120篇 |
耳鼻咽喉 | 282篇 |
儿科学 | 477篇 |
妇产科学 | 345篇 |
基础医学 | 2640篇 |
口腔科学 | 474篇 |
临床医学 | 1912篇 |
内科学 | 3613篇 |
皮肤病学 | 208篇 |
神经病学 | 2391篇 |
特种医学 | 716篇 |
外国民族医学 | 1篇 |
外科学 | 2565篇 |
综合类 | 241篇 |
一般理论 | 14篇 |
预防医学 | 1949篇 |
眼科学 | 710篇 |
药学 | 1735篇 |
中国医学 | 44篇 |
肿瘤学 | 1235篇 |
2023年 | 81篇 |
2022年 | 62篇 |
2021年 | 300篇 |
2020年 | 198篇 |
2019年 | 305篇 |
2018年 | 404篇 |
2017年 | 322篇 |
2016年 | 314篇 |
2015年 | 369篇 |
2014年 | 576篇 |
2013年 | 890篇 |
2012年 | 1293篇 |
2011年 | 1369篇 |
2010年 | 727篇 |
2009年 | 616篇 |
2008年 | 1265篇 |
2007年 | 1383篇 |
2006年 | 1352篇 |
2005年 | 1403篇 |
2004年 | 1357篇 |
2003年 | 1255篇 |
2002年 | 1247篇 |
2001年 | 225篇 |
2000年 | 200篇 |
1999年 | 236篇 |
1998年 | 226篇 |
1997年 | 223篇 |
1996年 | 167篇 |
1995年 | 222篇 |
1994年 | 145篇 |
1993年 | 180篇 |
1992年 | 159篇 |
1991年 | 139篇 |
1990年 | 138篇 |
1989年 | 140篇 |
1988年 | 111篇 |
1987年 | 128篇 |
1986年 | 117篇 |
1985年 | 141篇 |
1984年 | 135篇 |
1983年 | 127篇 |
1982年 | 168篇 |
1981年 | 187篇 |
1980年 | 155篇 |
1979年 | 99篇 |
1978年 | 97篇 |
1977年 | 116篇 |
1976年 | 89篇 |
1975年 | 57篇 |
1974年 | 44篇 |
Background
Although it is known that women do not participate in trials as frequently as men, there are limited recent data examining how women recruitment has changed over time.Methods
We conducted MEDLINE search using a validated strategy for randomized trials published in New England Journal of Medicine, Lancet, and Journal of the American Medical Association between 1986 and 2015, and included trials evaluating pharmacologic or nonpharmacologic therapies. We abstracted data on demographics, intervention type, clinical indication, and trial design characteristics, and examined their relationships with women enrollment.Results
In total, 598 trials met inclusion criteria. Women enrollment increased significantly over time (21% between 1986 and 1990 to 33% between 2011 and 2015; Pfor trend < 0.001) and did not differ by journal or funding source. Women enrollment varied with clinical indication, comprising 37% for non–coronary artery disease vascular trials, 30% for coronary artery disease trials, 28% for heart failure trials, and 28% for arrhythmia trials (P < 0.001), which were all significantly lower than the expected proportion in disease populations (P < 0.001). Women enrollment varied with trial type (31%, 29%, and 26% for pharmacologic, device, and procedural trials, respectively; P = 0.001). These findings were corroborated using multivariable analysis. We found significant positive correlations between women enrolled, and mean age and total number of participants. Fewer women were enrolled in trials reporting statistically significant results than those who did not (P = 0.001).Conclusions
Although enrollment of women has increased over time, it remains lower than the relative proportion in the disease population. Future studies should elucidate the reasons for persistent under-representation of women in clinical trials. 相似文献Materials and Methods: The first tier of testing utilized the Organization for Economic Co-operation and Development (OECD) QSAR Toolbox to perform an in silico evaluation of the skin irritation potential of the product ingredients, and the second tier of testing utilized an OECD in vitro guideline test to evaluate the skin irritation potential of each product.
Results: Thirty-two ingredients were evaluated using the OECD QSAR Toolbox profiler for the tier one analysis; nine ingredients received a structural alert for skin irritation/corrosion. In the tier two in vitro analysis, the evaluated cleansing conditioner products were all classified as non-irritants.
Conclusions: These results provide evidence that use of the evaluated commercially available cleansing conditioners would not be expected to cause skin irritation among consumers. Additionally, this study demonstrates that the presence of structural alerts does not always accurately predict the safety of a product, as focused tier-based testing is necessary to comprehensively evaluate a product. This study illustrates a tier-based safety assessment approach, applicable to a wide variety of health endpoints, which efficiently and adequately evaluates the safety of personal care and cosmetic products and their ingredients. 相似文献